Breast Cancer Clinical Trials in North Carolina

Showing 361-361 of 361 trials

Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer

NCT00081796

The purpose of this clinical trial is to determine if RPR109881 is a better treatment than capecitabine (Xeloda) for advanced breast cancer in patients that no longer benefit from docetaxel and/or paclitaxel.

Breast CancerMetastases

Sanofi438 participantsStarted Apr 2004

Birmingham, Alabama, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +184 more locations

Breast Cancer Trial of RPR109881 Versus Capecitabine in Male or Female Patients With Advanced Breast Cancer

Breast Cancer Trials in Other Cities

Other Conditions in North Carolina